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Integration of human papillomavirus (HPV) DNA into 
the host cell genome is believed to be essential for 
malignant progression. However unambiguous detec- 
tion of the physical state of HPV is a difficult and time- 
consuming procedure. To resolve this issue a simple, 
rapid and highly sensitive technique of polymerase 
chain reaction (PCR) has been utilized for detecting the 
physical state of HPV-16 DNA. Investigations were 
carried out in 122 cervical specimens comprising the 
whole spectrum of cervical lesions starting from 
cervical dysplasia to invasive carcinoma including 
HPV-16-positive normal controls. A pair of oligo- 
nucleotide primers specific to the E2 open reading 
frame, which is often deleted or disrupted following 
HPV integration, was used for the study. Distinction 
between episomal and integrated forms of viral DNA 
was accomplished bydetecting amplification of the E2- 
specific fragment (1139 bp) in the PCR product. The 
PCR results were compared with those obtained by the 
conventional methods of Southern blotting, two- 
dimensional gel electrophoresis and chromosomal in
situ hybridization; a high degree of agreement was 
observed between the methods. The findings indicate 
that although integrated forms of HPV-16 DNA were 
detected in more than 70% of cervical cancer speci- 
mens, integration was less frequent (23%) in severe 
dysplasia nd carcinoma in situ. Only 2.5 % of cases 
showed both episomal and integrated forms ofHPV-16 
DNA. The difference between episomal and integrated 
forms was statistically significant (P<0.01).  The 
absence of integration in about 30% of cancer cases 
suggests that integration of HPV may not be necessary 
for malignant progression and alternative mech- 
anism(s) of malignant transformation may occur with- 
out HPV integration. The PCR test thus provides an 
effective complement to Southern blotting and two- 
dimensional gel electrophoresis for accurate detection 
of the integration of HPV DNA. 
Introduction 
Cancer of the uterine cervix is the most common 
-malignant tumour in Indian women (Luthra et al., 1987; 
WHOBulletin, 1986; Murthy et al., 1990). Infection with 
specific human papillomavirus (HPV) types has been 
considered to be the major aetiological factor for the 
development of this disease (Diirst et al., 1983; zur 
Hausen, 1989b). In India as many as 98% of cervical 
carcinoma cases are found to harbour HPV DNA (Das et 
al., 1992), a frequency not seen in other countries. The 
most prevalent type is HPV-16 while the frequency of 
HPV-18 and other types is either very low or zero 
(Pfister, 1987; Gissmann et al., 1987; Das et al., 1989, 
1992). Since it is generally believed that integration of 
viral DNA into the host cell genome may be an essential 
prerequisite for malignant progression (Dtirst et al., 
1985; Gissmann et al., 1987; Schneider-Maunoury et al., 
1987; zur Hausen, 1989a), there hive been several 
studies (Baker et al., 1987; Boshart et al., 1984; Diirst et 
al., 1986; Gissmann et al., 1984; Lehn et al., 1985; 
McCance et al., 1983; Riou et al., 1985; Spence t al., 
1988) analysing the physical state of HPVs which may 
serve as a prognostic indicator for the preneoplastic 
lesions that are likely to progress to cancers. Furthermore 
it may offer clue(s) for understanding the mechanism(s) 
involved during the process of cervical carcinogenesis. 
All these studies have utilized standard methodologies 
involving a number of Southern blots and two-dimen- 
sional (2D) gel electrophoresis, techniques which are 
cumbersome and ti~e-consuming and require a large 
amount of biopsy DNA. Since biopsies are generally not 
available from preneoplastic or early neoplastic lesions 
and as the yield of DNA from cervical scrapes of 
normalJy small cervical dysploasias i often inadequate, 
we have designed a pair of oligonucleotide primers to 
detect he physical state of HPV by polymerase chain 
reaction (PCR). 
It is known that integration of HPV usually disrupts or 
deletes the E1 or E2 open reading frames (ORFs) 
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Table 1. Specification o f  HPV-16-specific oligonucleotide sequences used as primers and human 
[3-globin gene in PCR 
Primer region Nucleotide sequence 
Nucleotide Amplimer 
sequence length 
localization (bp) 
E2-1 5'-AGG ACG AGG ACA AGG AAA A-3' 2734~2753 1139 E2-2 5'-GGA TGC AGT ATC AAG ATT TG-3' 3853-3872 
URR-1 5'-AAG GCC AAC TAA ATG TCA C-3' 7763-7781 217 URR-2 5'-CTG CTT TTA TAC TAA CCG G-3' 57-75 
E6-1 5'-ATG CAC CAA AAG AGA ACT GC-3' 83-102 477 E6-2 5'-TTA CAG CTG GGT TTC TCT AC-3' 540-559 
E7-1 5'-TGC ATG GAG ATA CAC CTA CA-3' 563-582 291 E7-2 5"-GGT TTC TGA GAA CAG ATG GGG-3" 834-854 
fl-Globin-1 5'-GAA GAG CCA AGG ACA GGT AC-3' 268 fl-Globin-2 5'-CAA CTT CAT CCA CGT TAC ACC-3' 
(Awady et al., 1987; Choo et al., 1987, 1988; Schwarz et 
al., 1985), which could lead to over-expression f E6/E7 
oncoproteins and subsequent malignant ransformation 
(Choo et al., 1988; Schwarz et al., 1985). If this is true, 
there will be an absence of amplification of the E2 gene 
sequences in the PCR product following integration, or 
vice versa. Based on this hypothesis, a pair of oligonu- 
cleotide primers from the downstream E2 ORF of the 
HPV-16 genome has been synthesized and used for the 
present study to analyse the physical state of the virus in 
tumour DNA. The PCR results were compared to those 
obtained by Southern blotting, 2D gel electrophoresis 
and in situ hybridization to confirm the specificity and 
reliability of the PCR technique. We report hat the PCR 
method offers easy detection of unintegrated viral DNA 
sequences and provides an effective complement to 
Southern blotting and 2D gel electrophoresis foraccurate 
analysis of the physical state of HPV DNA. 
Methods 
Study population and specimens. A total of 21 carcinoma insitu (CIS) 
and 59 specimens ofdifferent grades of dysplasias including 10 normal 
controls, which were diagnosed histo- or cytopathologically (see Table 
1) and found positive for HPV-16 DNA, were used for the present 
study. Also, 42 HPV-16-positive invasive carcinoma specimens, which 
had been analysed earlier for the physical state of HPV by combined 
restriction digestion and 2D gel electrophoresis, were also employed for 
the PCR test. 
DNA extraction. The tissue biopsies collected in culture medium 
(Dulbecco's MEM) were immediately divided into three parts. One 
part was used for histology and a second part for chromosome 
preparation. The rest was kept frozen in a deep freezer (at - 70 °C) and 
was later used for DNA extraction. The detailed DNA extraction 
method is described elsewhere (Das et al., 1992). Briefly, following 
homogenization in 2 ml of 10 mM-Tris-HCl and 1 mM-EDTA (pH 8.0), 
the tissue was suspended in equal volumes of 3 ~ SDS/Sarkosyl and 
digested with 100 ~tg/ml proteinase K (Boehringer-Mannheim) for 1 to 
2 h at 37 °C. DNA was extracted with phenol-chloroform-isoamyl 
alcohol three times. DNA was precipitated with 3 M-sodium acetate 
(pH 5.0) and absolute thanol. Cervical scrapes from dysplasia cases 
and normal controls were collected in PBS and DNA was extracted 
according to a newly developed method (Gopalkrishna et al., 1992) 
employed routinely in our laboratory. The purity and concentration f 
DNA was determined in ethidium bromide-stained mini-gels. 
Restriction enzyme digestion and gel electrophoresis. Ten ~tg of total 
cellular DNA from each sample was digested first with PstI to detect 
HPV-16-positive cases with the authentic PstI cleavage pattern. To 
detect shifting of off-sized bands, 10 to 15 ~tg biopsy DNA was digested 
with no-cut (HindllI), single-cut (BamHI) and multicut (PstI) enzymes 
for HPV-16, and was electrophoresed in a 1% agarose gel at 30 V for 16 
to 20 h. 
2D gel electrophoresis. To differentiate between linear and circular 
extrachromosomal HPV DNA molecules, 2D gel electrophoresis was 
done using undigested/sheared DNA or DNA incubated with a no-cut 
enzyme, HindIII-digested turnout DNA. Following separation in a 
0-4% agarose gel in the first dimension, DNA was again electrophor- 
esed in the second imension i  0,8 % agarose gels (Diirst et al., 1985; 
Wettstein & Stevens, 1982). 
Southern blot and hydridization. After electrophoresis the gels were 
stained in ethidium bromide and photographed under a short-wave u.v. 
transilluminator. Gel-separated tumour DNA was transferred on to 
Gene-Screen Plus membranes (DuPont) by the method of Southern 
(1975) with certain modifications. Following prehybridization at 42 °C 
for 1 to 2 h, the filters were hybridized with a 32p-labdled HPV-16 
probe (Diirst, 1987). Prototype HPV-16 DNA was made vector-free 
using gel electrophoresis, purified on a DEAE membrane and was 
nick-translated to a specific activity of 1 × 108 to 2 x 108 c.p.m./l*g 
DNA. Hybridization was performed under stringent conditions (Tin 
-20 °C). The hybridization mix contained 50~ formamide, 5 x SSC, 
0.02~ Denhardt's solution, 0-25 lag/ml tRNA and 50 mM-Na3PO4 and 
incubation was at 42 °C for 16 to 20 h. One genome quivalent ofHPV- 
16 DNA (10 pg) was used as a positive control marker to check the 
sensitivity of hybridization. 
Dot blot hybridization. Six to eight lag of DNA extracted from cervical 
scrape cell samples was denatured at65 °C for 30 rain and then chilled 
immediately on ice and blotted onto a nitrocellulose membrane using a 
dot blot apparatus (Minifold I; Schleicher & SchfiU). After either 
baking at 80 °C for 1 h or cross-linking under u.v. light, the membrane 
was hybridized under stringent conditions (Tm -20  °C) using 32p. 
labelled HPV probes. 
PCR. For detection of integration, two specific oligoprimers from 
the downstream E20RF of the HPV-16 genome between ucleotides 
2734 and 3872 were used. In addition, oligonucleotide primers from the 
upstream regulatory region (URR) and E6/E70RFs of HPV-16 and a 
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pair of primers from the human//-globin ge e were used to check HPV 
positivity as well as the purity of tumour DNA for the PCR test. The 
primers were synthesized in an Applied Biosystems DNA Synthesizer 
(Model 381A, Applied Biosystems) and were purified in NAP-10 
columns (Pharmacia). The primer sequences are presented in Table 1. 
PCR amplification (Saiki et al., 1988) was carried out sing about 50 
to 100 ng of purified tumour DNA in 50 or 100 ~tl reaction mix 
containing 1 p.M of each primer, 50 mM-KC1, 10 mM-Tris-HCl pH 8.3, 
2-5 mM-MgC12, 75 gg/ml BSA, 200 ~tM of each dNTP and 1 to 2 units of 
Taq DNA polymerase (Cetus Corporation). The reaction mix was 
overlaid with 50 ~tl mineral oil in order to avoid evaporation. 
Amplification was done for 35 to 40 cycles in a Cetus DNA Thermal 
Cycler (Perkin-Elmer Cetus). The first cycle was 94 °C for 5 min 
(denaturing), 55 °C for 1 min (annealing) and 72 °C for 2 min 
(extension) followed by 38 cycles each at 94 °C for 1 min, 55 °C for 
1 rain and 72 °C for 2 min. The last cycle was as above except hat 
the extension period at 72 °C was extended up to 7 rain. After 
amplification, 15 to 20 ~tl of the mix was electrophoresed in a 3% 
Nusieve-agarose gelwith ethidium bromide and photographed under a 
u.v. transilluminator. 
Chromosome preparation fr m turnout biopsy specimens and in situ 
hybridization. To confirm integration of HPV DNA into host cell 
chromosomes, attempts were made to visualize integration sites in 
tumour chromosomes by in situ hybridization. A part of the biopsy 
specimen collected in tissue culture medium (DMEM) was immedi- 
ately processed for either direct preparation or primary culturing for 
chromosome preparation. 
Chromosome preparation. The free tumour cells along with minced 
tumour tissue were incubated at 37 °C in 5 ml medium supplemented 
with serum and colcemid (0.02 btl/ml) for 5 to 6 h. Following 
centrifugation the cell pellet was given a hypotonic treatment for 15 to 
20 rain in 0-75 M-KC1 and the cells were fixed in methanol : acetic acid 
(3 : 1) fixative and washed three or four times in fresh fixative. Air-dried 
chromosome slides were prepared by making a final cell suspension i
0-5 ml freshly prepared chilled fixative. 
Alternatively, a part of the tumour tissue was denatured by trypsin or 
collagenase treatment, washed in PBS and cultured in DMEM 
supplemented with 10~ foetal calf serum (FCS) and antibiotics. 
Within 7 to 10 days when the culture was almost confluent, it was 
harvested for chromosome preparation following prolonged colcemid 
treatment. 
In situ hybridization. Chromosome in situ hybridization was carried 
out using a method used for single copy gene localization (Neel et al., 
1982). A vector-purified 8 kb insert of HPV-16 was nick-translated to a 
specific activity of I × 108 or 2 × 108 c.p.m./~tg DNA using three 3H- 
labelled nucleotides (dTTP, dCTP and dATP, Amersham). Following 
proteinase K and RNase treatment of slides, the chromosomal DNA 
was denatured in70~ formamide in2 x SSC for 3 min. Hybridization 
was performed for 48 h at 42 °C in a moist chamber. Following washing 
and drying, the slides were coated with Kodak NTB II or III nuclear 
track emulsion (Eastman Kodak) in the dark, and were stored in the 
dark at 4 °C under moisture-free conditions for 5 to 6 weeks. The slides 
were developed in D-19b developer, stained in 5~ Giemsa in 
phosphate buffer pH 6.8 and observed under a Zeiss photomicroscope 
(Germany) using oil immersion objectives. 
Results 
Presence of HPV-16 genome in all invasive cervical 
carcinoma, CIS and dysplasia cases 
All invasive cervical cancer biopsy specimens diagnosed 
histopathologically were initially screened using the 32p_ 
HPV 
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Fig. 1. Southern blot hybridization analysis of HPV-16 DNA se- 
quences in cervical cancer biopsy specimens. Ten micrograms of 
cellular DNA was digested with PstI, electrophoresed in a 1 ~ agarose 
gel and hybridized with a 3zp-labelled HPV-16 + 18 DNA probe under 
stringent conditions (Tin -20  °C). Results are shown for 10 specimens 
(lanes 1 to 10) of which seven were positive (lanes 1, 3, 4, 6, 7, 9 and 10) 
for HPV-16, The characteristic Pstl cleavage pattern of HPV-16 is 
shown by arrows and the fragment sizes are indicated in kilobases. The 
first two lanes served as positive control markers having 10 and 50 pg of 
HPV-16 and -18 DNA respectively. 
labelled vector-free 8 kb insert of HPV-16. PstI, a multi- 
cut enzyme for HPV-16, was used to detect authentic 
restriction fragments of the viral genome. Forty-two 
HPV-16-positive specimens which showed the charac- 
teristic PstI cleavage pattern, i.e. 2-8, 1.9, 1.6, 1.0 and 0.5 
kb bands, and had at least five to 10 copies of the viral 
genome were selected for the analysis of the physical 
state. The autoradiogram presented in Fig. 1 shows the 
PstI-specific fragments (arrows)of HPV-16. There are 
cases (lanes 3 and 4) which showed a very high copy 
number of HPV- 16 including certain genomic rearrange- 
ments and the presence of off-sized fragments. All these 
HPV-16-positive specimens were employed for physical 
state analysis by four different molecular techniques. 
Since the amounts of DNA extracted from cervical 
scrapes of dysplasia nd control cases were insufficient, 
these were confirmed by dot blot hybridization and the 
physical state was analysed by PCR only. All 122 HPV- 
16-positive samples were found to show amplification of
both HPV-16-specific primers as well as the fl-globin 
gene in PCR (See Fig. 2). 
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Fig. 2. Amplification foligonucleotide primers from the URR region 
of HPV-16 along with human fl-globin gene as an experimental control. 
First three lanes areHaelIl-digested q~X174 DNA size markers, HPV- 
16 plasmid DNA showing 217 bp amplification a d human placental 
DNA showing 268 bp fl-globin gene amplification respectively. Lanes 
1 to 5 are cervical carcinoma DNA samples showing amplification f 
HPV-16 as well as fl-globin gene primers in the same reaction mix. 
The majority of tumour DNA showed shifts of off-sized 
fragments after digestion with various enzymes 
In order to determine the physical form of viral DNA, 10 
to 15 ~tg of tumour DNA was digested with a no-cut 
enzyme for HPV-16 (HindlII), a single-cut enzyme 
(BamHI) and a multicut enzyme (PstI). These digested 
tumour DNAs together with undigested sheared DNA 
samples and one genome equivalent (10 pg) of vector- 
free HPV-16 DNA were electrophoresed on a 1% 
agarose gel. Southern blot hybridization was performed 
with an HPV-16 DNA probe. Fig. 3 is a representative 
autoradiograph s owing results for two specimens (a, b). 
For specimen (a) the lanes UD and NC show three forms 
of high Mr DNA and also, as expected, lanes SC and MC 
show the single 8 kb band and five PstI fragments 
respectively. Clearly, there is an absence of off-sized 
fragments and this is indicative of the episomal DNA 
form. In contrast, in specimen (b), there were a number 
of off-sized fragments (thin arrows) along with authentic 
BamHI and PstI fragments (thick arrows) and a single 
high Mr DNA band in lanes UD and NC. This suggests 
that HPV DNA was in an integrated state and is 
indicative of a tandem integration of HPV-16. Of 42 
specimens, 29 (69%) showed integrated forms, and in 11 
(26%) cases HPV DNA was found to be exclusively 
episomal. Only two cases (4.76%) revealed the presence 
of both episomal and integrated forms; in these we did 
not observe either off-sized bands or E2 amplification 
(see Tables 2 and 3). 
kb 
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Fig. 3. Southern blot hybridization of two cancer biopsy DNA 
following combined digestion with no-cut (NC), HindlII, single-cut 
(SC), BamHI, and multicut (MC), PstI, in addition to lanes of 
undigested (UD) DNA. In the episomal form (a) it shows characteristic 
BamHI and PstI cleavage patterns along with three forms of high Mr 
DNA in UD and NC but no indication f additional off-sized 
fragments. In the integrated form (b) there is a shift in light off-sized 
fragments (thin arrows) in lanes SC and MC along with authentic PstI 
fragments (thick arrows) suggesting integration f head-to-tail tandem 
repeats at more than one site. 
21) gel electrophoresis : majortity of single track linear 
DNA molecules 
2D gel electrophoresis was carried out using undigested 
or HindlII-digested tumour DNA (HindlII does not cut 
in HPV-16 DNA) to reveal inear or circular extrachro- 
mosomal DNA molecules of HPV. The integration of 
HPV DNA is indicated by a single track of linear DNA 
molecules in the second imension of an 0.8 % agarose gel 
following separation in 0.4% agarose in the first 
dimension. Representative Southern blot hybridization 
pictures presented in Fig. 4(a, b) and 5(a, b) show the 2D 
gel analysis of the same two samples depicted in Fig. 3 (a) 
and (b) respectively. Fig. 4(a, b) with a track of circular 
DNA molecules is indicative of the episomal form, 
detected in 13 samples (31%). Some linearized DNA is 
due to degradation. All 42 specimens analysed by 2D gel 
electrophoresis showed perfect correlation with the 
results obtained by the multiple enzyme digestion assay. 
All the 29 integrated samples (69%) with off-sized 
fragments revealed a single track of linear DNA 
molecules (Table 2). This confirmed the integrated state 
of HPV-16 DNA in a majority of invasive cervical 
cancers. 
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Table 2. Physical state of HPV-16 DNA in precancerous and cancerous lesions of the uterine 
cervix and in normal samples 
No. of Episomal + 
Histo-cytological cases Episomal fo rm In tegrated  integrated 
grade analysed (n = 122) (~) form (%) form (~) 
Normal 10 10 (100) 0 0 
Mild dysplasia 22 22 (100) 0 0 
Moderate dysplasia 17 17 (100) 0 0 
Severe dysplasia 10 9 (90) 1 (10) 0 
Carcinoma insitu 21 15 (71.43) 5 (23.8) 1 (4.76) 
Invasive carcinoma 42 11 (26-19) 29 (69-05) 2 (4.76) 
Table 3. Analysis of physical state of HPV-16 DNA in invasive cervical cancers by different 
molecular methods 
Episomal + 
Molecular method Total no. of Episomal fo rm Integrated integrated 
employed cases tudied (%) form (~) forms (~) 
Combined restriction 42 13 (30.95) 29 (69.05) 0 
enzyme digestion assay 
2D gel electrophoresis 42 13 (30.95) 29 (69.05) 0 
E20RF-specific primer- 42 11 (26.19) 29 (69.05) 2 (4.76) 
directed amplification 
in PCR 
Chromosomal in situ 3 0 3 (100) 0 
hybridization 
Absence of PCR amplification of E20RF  primers in the 
majority of cervical cancer specimens 
It is generally accepted that because of integration the E2 
ORF region of the HPV genome is deleted or disrupted 
(Awady et al., 1987; Choo et al., 1987, 1988; Schwarz et 
al., 1985). If this is true, there will be no amplification of 
the E2 seqeunces in PCR. In the present study, out of 42 
invasive carcinoma samples only 11 showed amplifica- 
tion and the others showed no amplification of the 
expected 1139 bp fragment (see Fig. 6a). In two samples 
off-size fragments and linear DNA molecules could not 
be detected, suggesting an episomal configuration. 
However, as these samples also failed to show E2 
amplification, suggestive of integration, they may con- 
tain episomal as well as integrated forms (Table 3). Using 
PCR, 73-8~ (31/42) were found to be in integrated forms 
whereas only 26.2~ (11/42) were in the episomal form 
(Tables 2 and 3). Fig. 6 (a) shows the results from eight 
carcinoma samples; only three (lanes 4, 6 and 7) were 
found to contain integrated HPV DNA, as revealed by 
the absence of amplification. 
The majority of precancerous lesions show amplification of 
the E20RF sequences 
Since the amount of DNA extracted from cervical 
scrapes of dysplasia nd CIS cases was not sufficient o 
carry out Southern blotting and 2D gel electrophoresis, 
these were analysed by PCR only. Of 49 dysplasia cases, 
consisting of 22 mild, 17 moderate and 10 severe 
dysplasias, all showed E2 amplification except one 
(2.04~); an absence of amplification was recorded in 
five cases (23.8~o) of 21 CIS specimens analysed. Only 
one case (4.76) revealed HPV in both the episomal and 
integrated states (see Table 2). Fig. 6 (b) shows the results 
for eight representative CIS samples of which only one 
(lane 1) showed the absence of E2 amplification, hence 
integration. The last two lanes (lanes 9 and 10) in the 
lower panel are control male and female lymphocyte 
DNA. All the 10 normal controls howed the presence of 
extrachromosomal DNA as scored by the appearance of
a 1139 bp E2-specific band in PCR. 
In situ detection of HPV-16 DNA integration in tumour 
chromosomes 
In a preliminary attempt, chromosomes from only three 
invasive cancer biopsy specimens which were also 
analysed by other methods could be prepared by a direct 
method for visualization of integration sites on chromo- 
somes. Mostly polyploid cells were observed with 
chromosome numbers varying from 60 to 70 with a mode 
of 66 chromosomes. Various structural abnormalities 
were also observed. Fig. 7(a, b) shows the in situ 
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Fig. 4. Two-dimensional gel electrophoresis of HPV-16-positive DNA 
(10 ~tg) from cervical cancer biopsy showing episomal state of viral 
genome. (a) Undigested/sheared DNA shows viral DNA in three forms 
in the first dimension (separated in a 0.4~ agarose gel). Form I is 
supercoiled virion DNA, form II nicked circular and form III linear 
DNA. (b) One of the first dimension lanes was separated again in an 
0.8~ agarose gel in the second dimension by rotating the gel lane 
through 90 ° and casting a new gel; a track of circular DNA molecules 
was detected. Indication of a light linearized DNA track is due to 
degradation/nicking of DNA during preparation. 
(a) 
~ (b) 
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Fig. 5. Two-dimensional gel electrophoresis of HPV-positive biopsy 
DNA (10 ~tg) showing integrated state of viral DNA. (a) First 
dimension (0.4~ gel), undigested/sheared DNA showing asingle band 
of high M, (>23-1 kb) viral DNA; (b) second dimension (0.8%), one 
track of linear DNA molecules indicating integrated state of HPV 
DNA within the host genome. 
hybridization and integration sites (arrows) of HPV-16 
DNA in tumour chromosomes. There are three integra- 
tion sites in Fig. 7 (a) whereas 7(b) shows four integration 
sites. It appears from the grain concentration that the 
HPV copy number may vary from about five (Fig. 7b) to 
50 (Fig. 7a). In view of their poor morphology and 
inadequate number of metaphases, no attempts were 
made to band and identify the chromosomes. The three 
specimens in which in situ localization could be done had 
already been found to have integrated forms f HPV 
DNA by three other molecular approaches. HPV DNA 
in the same specimen (Fig. 7a) can be seen integrated in 
Fig. 3(b), 5(a, b) and 6(a), lane 4. 
Fig. 6. Amplification of HPV-16 E20RF-specific oligoprimers, E2-1 
and E2-2, in (a) invasive carcinoma nd (b) CIS DNA by PCR. Twenty 
~tl PCR products show amplification of E2 sequences between 
nucleotides 2734 and 3872, i.e. 1139 bp, in 3~ NuSieve agarose gel 
etectrophoresis, ethidium bromide staining and u.v. irradiation. (a) 
Carcinoma DNA samples howing absence of E2 amplification in 
three lanes (4, 6 and 7) out of eight cases. (b) Lanes 2 to 8 (2 to 5 in upper 
and 6 to 8 in lower panel) show E2 amplification i dicating episomal 
state of HPV; the absence of amplification i  lane 1 is indicative of 
integrated viral DNA. Lanes 9 and 10 in the lower panel contain 
lymphocyte DNA from normal male and female controls respectively. 
Discussion 
Observation of PstI-specific restriction fragments for 
HPV-16 on Southern blotting is generally taken to be a 
reliable method for detection of the viral genome in 
cervical lesions. As shown in Fig. 1 we have detected the 
characteristic PstI cleavage pattern of HPV-16 in all 
HPV-I 6-positive cervical cancer specimens and this is in 
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Fig. 7. Directly prepared metaphase chromosomes from invasive 
cancer biopsy specimens showing HP¥-16 integration sites involving 
three chromosomes (a) or four chromosomes (b) (arrows). Chromosome 
slides were hybridized with 3H-labeUed dTTP, dCTP and dATP under 
stringent conditions and coated with Kodak NTB II nuclear t ack 
emulsion. 
agreement with earlier eports (Yoshikawa et al., 1985; 
Scholl et al., 1985 ;Lancaster etal., 1986; Meanwell et al., 
1987). However some samples showed deletions or 
certain genomic rearrangements leading to an atypical 
pattern which also may be indicative of integration of 
HPV-16 DNA into the host cell genome (Lehn et al., 
1985; Millan et al., 1986; Choo et al., 1987; Takebe t al., 
1987; Wilczynski et al., 1988). In almost all cases, two 
PstI  fragments, i.e. 1.9 and 1.6 kb, representing the 
E6/E7 and L1/L2 regions respectively, are found to be 
maintained (Fig. 1). This indicates that the presence of 
these specific viral sequences are essential for main- 
tenance of a malignant phenotype. 
It has been reported that HPVs such as types 6 and 11 
detected in benign lesions and warts are often present in 
an episomal form (McCance et al., 1983; Gissmann et 
al., 1984) whereas HPV types 16 and 18 associated with 
invasive cervical cancers and CIS are usually integrated 
into the host genome (D(irst et al., 1985; Schwarz et al., 
1985; Lehn et al., 1985; Riou et al., 1985; zur Hausen, 
1989b). These two oncogenic HPVs have also been 
shown to be in an integrated form in a majority of 
established cell lines derived from cervical carcinomas 
(Boshart et al., 1984; Yee et al., 1985; Tsunokawa et al., 
1986, Mincheva et al., 1987; Baker et al., 1987; Spence t 
al., 1988). It is, therefore, suggested that integration of 
viral DNA into the host genome may be an essential 
prerequisite for malignant transformation. I  the present 
study, as many as four different molecular techniques 
were employed (see Table 3) and the results indicate 
about 70~ integration of HPV-16 DNA in cervical 
cancer specimens. The basis of our interpretation was as 
follows. (i) Combined igestion with no-cut (Hindl I I ) ,  
single-cut (BamHI )  and multi-cut (PstI) enzymes and 
comparison of band patterns with that of undigested 
DNA, irrespective ofcopy number and minor earrange- 
ments ofHPV DNA (Fig. 3a, b), showed off-sized bands. 
The detection of bands larger than 23-1 kb (see Fig. 3 b) 
in lanes UD and SC was indicative of integration. In 
addition the presence and/or shifting in the size of off- 
sized fragments in lanes SC and MC in Fig. 3(b) together 
with the authentic BarnHI and PstI cleavage pattern 
respectively, suggests integration of head-to-tail tandem 
repeats at more than one site (Dfirst et al., 1983; Seedorf 
et al., 1985). All the off-sized fragments detected cannot 
be due to minor rearrangements only. (ii) These results 
were confirmed by 2D gel electrophoresis in which linear 
and circular forms of viral DNA can be differentiated 
(see Fig. 4a, b and 5a, b). The detection of a single track 
of linear HPV DNA molecules rather than the circular 
DNA track that is characteristic of the episomal form is 
considered to be due to an integrated state of viral DNA. 
(iii) There was no PCR amplification of specific 
oligoprimers from the downstream E2 ORF (see Fig. 6a, 
b), since viral integration leads to disruption or deletion 
of E1 and E2 ORFs and perhaps deregulation of 
expression of other early genes (Schwarz et al., 1985; 
Lehn et al., 1985; Choo et al., 1987; Baker et al., 1987; 
Cripe et al., 1987; Shirasawa et al., 1988; Takebe et al., 
1987; Wilczynski et al., 1988). (iv) Finally, we used in situ 
localization and visualization of HPV-16 DNA integra- 
tion sites in tumour chromosomes (see Fig. 7a, b). 
There was a high degree of agreement between the 
observations obtained by these four different techniques, 
which overall demonstrate that integrated forms of 
HPV-16 DNA are present in a majority (69 ~) of cervical 
cancer specimens (Table 2). This is in accordance with 
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the findings of several authors (Diirst et al., 1985, Diirst, 
1987; Lehn et al., 1985; Riou et al., 1985; zur Hausen, 
1989b; Cullen et al., 1991) but is not in conformity with 
the recent report of Matsukura et al. (1989) who showed 
that the frequency of integration of HPV-16 DNA in 
cervical carcinoma isonly 30 ~o compared to the 70 ~o that 
we and others have observed. 
Unambiguous detection of the physical state of HPV 
DNA in tumour DNA specimens is a difficult and 
cumbersome procedure. Generally, it poses problems 
when both episomal as well as integrated forms are 
present in a specimen, or a small sequence of HPV DNA 
is integrated. Thus there have been several conflicting 
reports (Cullen et al., 1991 ; DiLuca et al., 1986; Lehn et 
al., 1988; Matsukura et al., 1989). To resolve this issue, 
the present study was initiated to develop a convenient 
and sensitive method for detection of HPV DNA 
integration. Because of its high sensitivity, the recently 
developed PCR (Saiki et al., 1988) is rapidly becoming 
the preferred method for various diagnostic purposes. 
The present PCR results compare well with those 
obtained by standard procedures. In turnout DNA 
specimens, the frequent lack of amplification of E2 ORF 
sequences indicates that the E2 region is preferentially 
disrupted or deleted due to integration of HPV. The 
results for 42 carcinoma samples which were analysed by 
both Southern blotting and 2D gel methods are largely 
comparable with those obtained by the present PCR 
method. This was further confirmed by visualization of 
HPV DNA integration sites in tumour chromosomes 
prepared irectly from the same tissue specimens (Fig. 
7a, b). The PCR method thus facilitates the detection of 
a low level of HPV integration which may not be 
detected by conventional methods. It allows processing 
of a large number of samples at a time and requires a 
small amount of turnout DNA. However, to rule out the 
possibility of integration outside the 1139 bp region or at 
the El ORF region, additional sets of primers from these 
regions may have to be used for further confirmation. 
Alternatively, amplification of virus--cell junctions could 
be most appropriate, although it would be difficult to 
know the 'fusion sequences' of the junctions for every 
case without cloning and sequencing. Nevertheless, 
since PCR results are in good agreement with the results 
obtained by standard procedures, it can be reliably used 
for rapid analysis of the physical state of oncogenic 
HPV-16. This is most useful in screening pre-neoplastic 
or early neoplastic lesions from which biopsies are 
generally not available and the yield of DNA from 
scraped cervical cells is often inadequate. 
Although there are reports that about 50~ of 
integration events occur in preneoplastic lesions, par- 
ticularly those of CIN III cases (DiLuca et al., 1986; 
Lehn et al., 1988), we could detect only 19~ (n = 31) 
integration in these cases (severe dysplasia and CIS 
cases) (see Table 2). This is in sharp contrast to the recent 
report of Cullen et al. (1991) who could detect only 3~ 
integration in these cases. Observation of such a low 
frequency of integration may be due to either geographic 
variation or non-detection f small integrated sequences 
by conventional methods. The PCR test, therefore, can 
provide an effective complement toSouthern blotting or 
2D gel electrophoresis for an accurate detection of the 
physical state of HPV DNA. 
Although it has been suggested that integration of 
HPV DNA into the host cell genome is essential for 
malignant progression (Diirst et al., 1985; Gissmann et 
al., 1987; Schneider-Maunoury et al., 1987; zur Hausen, 
1989a, b) it seems unlikely that integration alone is 
sufficient to account for malignant proliferation. This is 
not only because of the absence of integration in about 
30 ~ of carcinomas as observed by us and others (Cullen 
et al., 1991) but is also supported by evidence from cell 
hybrids produced by fusion of HeLa cells and normal 
human fibroblasts or keratinocytes (Stanbridge, 1976). 
These hybrids contained HPV-18 in an integrated form 
but the malignant phenotype was not expressed 
(Schwarz et al., 1987; Stanbridge t al., 1982). Therefore 
a detailed understanding of the expression of HPV 
transforming enes, E6/E7, along with other growth 
regulatory cellular genes following infection by HPV 
may throw light on the mechanisms involved during the 
malignant progression of cervical esions. 
The HPV DNA probes used in this study were kindly provided 
by Professors H. zur Hausen, L. Gissmann and E. M. de Villiers of 
Deutsches Krebsforschungszentrum, Heidelberg, Germany. The 
authors are also grateful to Professor A. D. B. Malcolm, Biochemistry 
Department, Charing Cross and Westminster Medical School, 
London, U.K. for the initial gift of E2 oligonucleotide primers. 
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